Doxapram
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 697 publications
Pairing ampakine with brief hypoxia evokes phrenic neuroplasticity via a spinal NMDA receptor mediated mechanism.
Journal: Function (Oxford, England)
Published: July 17, 2026
Impact of changing open-label drug prescription policies on consent rates in a neonatal trial: a quasinatural experiment.
Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: April 17, 2026
Doxapram Exposure Was Not Associated With Adverse Neurodevelopmental Outcomes in Very Low Birth Weight Infants: A Monocentric Retrospective Cohort Study.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: April 05, 2026
The present and future of antiarrhythmic drugs.
Journal: JRSM cardiovascular disease
Published: February 23, 2026
Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.
Journal: BMJ paediatrics open
Published: November 21, 2025
Comparative Effects of Aminophylline, Caffeine, and Doxapram in Hypoxic Neonatal Dogs Born by Cesarean Section.
Journal: Animals : an open access journal from MDPI
Published: October 26, 2025
Role of Spontaneous Effort During Mechanical Ventilation on Lung Injury in Preterm Lambs.
Journal: American journal of respiratory and critical care medicine
Published: October 10, 2025
Pharmacological treatment for apnoea of prematurity-the need for an individualised approach.
Journal: Frontiers in pediatrics
Published: September 22, 2025
Oral doxapram for apnea of prematurity: A randomized dosage trial.
Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: July 15, 2025
Role of spontaneous effort during mechanical ventilation on lung injury in preterm lambs.
Journal: American journal of respiratory and critical care medicine
Published: June 09, 2025
Management of Apnoea in Extremely Preterm Infants: A European Survey.
Journal: Neonatology
Published: May 29, 2025
KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1.
Journal: Frontiers in pharmacology
Published: February 15, 2025
Last Updated: 09/26/2026